Latinas who had key roles in the development of the respiratory syncytial virus (RSV) and COVID-19 vaccines are hopeful their work can contribute to improving vaccination rates among Hispanics.
The big picture: Latinos in the U.S. have consistently low inoculation rates against the flu, polio, HPV or hepatitis, and are less likely than other racial or ethnic groups to be vaccinated against COVID-19, research shows.